CP-664511

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCP-664511
Drug Alias NameVLA-4 antagonists (Pfizer)CP-664511
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-4/beta-1 antagonistsVascular cell adhesion molecule 1 inhibitors
TargetsIntegrin alpha-4/beta-1Vascular cell adhesion molecule 1
Therapy Area/IndicationsPneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Global Research and Development
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Global Research and Development
Active IndicationsN/A
Inactive IndicationsPneumonia

Other Information

ATC CodeN/A
Related LinksN/A